Myocardial infarction

December 13, 2018

Molecular Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: Valproic acid (brand names: Convulex, depakote, epilim, stavzor and others), a drug used to treat seizures/epilepsy, increases the expression of ERBB2/Her2 and promotes dedifferentiation of cardiomyocytes, via up-regulation of its target gene, 13/December/2018, 11.41 pm

Molecular Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: Valproic acid (brand names: Convulex, depakote, epilim, stavzor and others), a drug used to treat seizures/epilepsy, increases the expression of ERBB2/Her2 and promotes dedifferentiation of cardiomyocytes, via up-regulation of its target gene, 13/December/2018, 11.41 pm https://genomediscovery.org/wp-content/uploads/2018/12/V.jpg 960 720 https://genomediscovery.org/wp-content/uploads/2018/12/V.jpg December 13, 2018 December 28, 2018

Introduction: What they say A recent study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was published, in the 6 April…

Probiotic-based Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: Probiotic Lactobacillus fermentum ZYL0401 increases the expression of ERBB2/Her2 and promotes dedifferentiation of cardiomyocytes, via down-regulation of its target gene, 2/December/2018, 10.29 pm

Probiotic-based Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: Probiotic Lactobacillus fermentum ZYL0401 increases the expression of ERBB2/Her2 and promotes dedifferentiation of cardiomyocytes, via down-regulation of its target gene, 2/December/2018, 10.29 pm https://genomediscovery.org/wp-content/uploads/2018/12/Probiotic-Lactobacillus-fermentum-ZYL0401-promotes-cardiomyocyte-dedifferentiation-and-proliferation.jpg 960 720 https://genomediscovery.org/wp-content/uploads/2018/12/Probiotic-Lactobacillus-fermentum-ZYL0401-promotes-cardiomyocyte-dedifferentiation-and-proliferation.jpg December 2, 2018 December 2, 2018

Introduction: What they say A recent study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was published, in the 6 April…

Molecular therapy for Myocardial infarction: Nucleolin, a nucleolar phosphoprotein that plays a role in the maturation of ribosomes, inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 20/August/2018, 7.21 pm

Molecular therapy for Myocardial infarction: Nucleolin, a nucleolar phosphoprotein that plays a role in the maturation of ribosomes, inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 20/August/2018, 7.21 pm https://genomediscovery.org/wp-content/uploads/2018/08/Nucleolin-attenuates-cardiac-ageing-and-pathogensis-associated-with-MIiocardial-infarction-through-up-regulation-of-PNUTS.jpg22.jpg 960 720 https://genomediscovery.org/wp-content/uploads/2018/08/Nucleolin-attenuates-cardiac-ageing-and-pathogensis-associated-with-MIiocardial-infarction-through-up-regulation-of-PNUTS.jpg22.jpg August 20, 2018 August 20, 2018

What they say: A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March 2013 issue of the journal Nature, by Prof Dimmler, Boon, and…